For example, researchers have constructed an NP that combines an anti-cytotoxic T lymphocyte-associated protein 4 (anti-CTLA-4) monoclonal antibody and mRNA encoding tumor antigen MUC1 for enhancing anti-tumor benefits. The gene discussed is CTLA4; the disease is neoplasm.